logo
Select company
Select metric
-5584.68%Free Cash Flow Margin
VS
Market
2
Sector
8
Industry
14
History
13
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information

Ticker

LYRA

Company Name

LYRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYRA THERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYRA - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -43M-5584.68%$ 770K
3/31/2025$ -56.59M-4775.27%$ 1.19M
12/31/2024$ -72.35M-4716.36%$ 1.53M
9/30/2024$ -80.9M-5499.66%$ 1.47M
6/30/2024$ -78.88M-4334.29%$ 1.82M
3/31/2024$ -73.06M-4348.81%$ 1.68M
12/31/2023$ -64.35M-4130.36%$ 1.56M
9/30/2023$ -56.7M-3984.4%$ 1.42M
6/30/2023$ -53.31M-4306.54%$ 1.24M
3/31/2023$ -47.45M-3635.71%$ 1.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at 0%.
  • Over the past 5 years, LYRA THERAPEUTICS INC's average FCF % has been -14544.11%.
  • The median FCF % for LYRA THERAPEUTICS INC during this period was -4320.41%
  • LYRA THERAPEUTICS INC reached its highest FCF % over the past 5 years at -574.19%.
  • The lowest FCF % recorded by LYRA THERAPEUTICS INC in the same timeframe -169957.14%

LYRA THERAPEUTICS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
APRE : APREA THERAPEUTICS INC -1514.98%BRTX : BIORESTORATIVE THERAPIES INC -1590.77%ERNA : ERNEXA THERAPEUTICS INC -2960.25%VYNE : VYNE THERAPEUTICS INC -8380.25%SXTP : 60 DEGREES PHARMACEUTICALS INC -759.84%LEXX : LEXARIA BIOSCIENCE CORP -1585.78%ICU : SEASTAR MEDICAL HOLDING CORP -2004.7%RLYB : RALLYBIO CORP -5517.87%IBIO : IBIO INC -3830%CODX : CO-DIAGNOSTICS INC -3311.3%

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for LYRA THERAPEUTICS INC is calculated as follows: FCF [ $ -22.92M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]

LYRA - Free Cash Flow Margin, Last 5 years

-169957.14%

Minimum

Sep 30, 2021

-574.19%

Maximum

Mar 31, 2022

-14544.11%

Average

-4320.41%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.87%
median7.4%
std19.48%